Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001825192-26-000002
Filing Date
2026-03-09
Accepted
2026-03-09 16:36:57
Documents
1
Period of Report
2026-03-05

Document Format Files

Seq Description Document Type Size
1 form4-03092026_080350.html 4  
1 form4-03092026_080350.xml 4 3970
  Complete submission text file 0001825192-26-000002.txt   5439
Mailing Address 400 ALEXANDER PARK DRIVE SUITE 301 PRINCETON NJ 08540
Business Address 400 ALEXANDER PARK DRIVE SUITE 301 PRINCETON NJ 08540 (609) 642-6670
PMV Pharmaceuticals, Inc. (Issuer) CIK: 0001699382 (see all company filings)

EIN.: 463218129 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O PMV PHARMACEUTICALS, INC. 8 CLARKE DRIVE, SUITE 3 CRANBURY NJ 08512
Business Address
Jalota Deepika (Reporting) CIK: 0001825192 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39539 | Film No.: 26735628